Works matching IS 2160763X AND DT 2024 AND VI 13 AND IP 7
Results: 13
Concentration‐QTc Modeling of the DPP‐4 Inhibitor HSK7653 in a First‐in‐Human Study of Chinese Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 7, p. 716, doi. 10.1002/cpdd.1418
- By:
- Publication type:
- Article
Pharmacokinetics of Fipaxalparant, a Small‐Molecule Selective Negative Allosteric Modulator of Lysophosphatidic Acid Receptor 1, and the Effect of Food in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 7, p. 819, doi. 10.1002/cpdd.1417
- By:
- Publication type:
- Article
Effect of Hepatic and Renal Impairment on the Pharmacokinetics of Dersimelagon (MT‐7117), an Oral Melanocortin‐1 Receptor Agonist.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 7, p. 729, doi. 10.1002/cpdd.1413
- By:
- Publication type:
- Article
Evaluation of the Clinical Drug‐Drug Interaction Potential of Pritelivir on Transporters and CYP450 Enzymes Using a Cocktail Approach.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 7, p. 755, doi. 10.1002/cpdd.1408
- By:
- Publication type:
- Article
Safety, Tolerability, and Pharmacokinetics of Anaprazole, a Novel Proton Pump Inhibitor, in Healthy Chinese Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 7, p. 782, doi. 10.1002/cpdd.1405
- By:
- Publication type:
- Article
Pharmacokinetics of Nitazoxanide Dry Suspensions After Single Oral Doses in Healthy Subjects: Food Effects Evaluation and Bioequivalence Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 7, p. 748, doi. 10.1002/cpdd.1402
- By:
- Publication type:
- Article
Clinical Pharmacology of GP40321 (Insulin Glulisine Biosimilar): Pharmacokinetic and Pharmacodynamic Comparability in a Hyperinsulinemic‐Euglycemic Clamp Procedure.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 7, p. 828, doi. 10.1002/cpdd.1401
- By:
- Publication type:
- Article
A Population Pharmacokinetic Assessment of the Effect of Food on Selumetinib in Patients with Neurofibromatosis Type 1‐Related Plexiform Neurofibromas and Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 7, p. 770, doi. 10.1002/cpdd.1400
- By:
- Publication type:
- Article
Nlmixr2 Versus NONMEM: An Evaluation of Maximum A Posteriori Bayesian Estimates Following External Evaluation of Gentamicin and Tobramycin Population Pharmacokinetic Models.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 7, p. 739, doi. 10.1002/cpdd.1395
- By:
- Publication type:
- Article
Safety, Tolerability, and Pharmacokinetics of Single‐ and Multiple‐Ascending Doses of Sunobinop in Healthy Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 7, p. 790, doi. 10.1002/cpdd.1394
- By:
- Publication type:
- Article
Effect of Strong CYP3A4 Inhibition, CYP3A4 Induction, and OATP1B1/3 Inhibition on the Pharmacokinetics of a Single Oral Dose of Sotorasib.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 7, p. 810, doi. 10.1002/cpdd.1392
- By:
- Publication type:
- Article
Pharmacokinetics, Safety, and Tolerability of Cedirogant in Healthy Japanese and Chinese Adults.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 7, p. 801, doi. 10.1002/cpdd.1386
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 7, p. 711, doi. 10.1002/cpdd.1120
- Publication type:
- Article